BEBM® Bronchial Epithelial Basal Medium. Available for immediate shipment.
Human cryopreserved stellate cells derived from liver
Note: This product is to be discontinued following depletion of current inventory. Please use our 200K and 1M yield parts for future needs (HUCLS-200K, HUCLS-1M)
Culture system containing BEBM® Bronchial Epithelial Cell Growth Basal Medium (CC-3171) and BEGM® Bronchial Epithelial Cell Growth Medium SingleQuots® Supplements and Growth Factors (CC-4175).
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
TheraPEAK® MSCGMTM Mesenchymal Stem Cell Growth Medium BulletKit® including the basal medium and supplements, which is GMP-produced and serum-free, 1 L.
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 25 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved Normal Human Bronchial Epithelial (NHBE) cells, screened and guaranteed for differentiation, in B-ALITM (Bronchial Air Liquid Interface) cell culture.
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
Natural Killer (NK) Cell Culture, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
References - X-Vivo™Overview of relevant references
-
Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic ResearchLonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
Cryopreserved Neural Cells and MediaLonza's Cryopreserved Neurons Offer Comparable Results to Fresh Cells
-
Instructions - Neural Progenitor Cell System, NHNPInstructions for Proper Use